Article
Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress
2025-09-04
Abstract excerpt
<title>Abstract</title> <p>Peripherally restricted cannabinoid CB1 receptor antagonists without central side effects hold promise for treating metabolic disorders including diabetes and obesity. In atherosclerosis, the specific effects of peripheral endothelial CB1 signaling remain incompletely understood. Here, we report the expression of the CB1 encoding gene CNR1 in arterial endothelial cells of human plaques....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5738917-a003-54c4-9857-4756cacfce9c
- DOI
- 10.21203/rs.3.rs-6944788/v1
